Form 4: MapLight CFO Executes Tax-Related Share Sale
Statement of Changes in Beneficial Ownership
Chief Financial Officer Vishwas Setia sold 2,922 shares of MapLight Therapeutics to cover statutory tax obligations.
Summary
- CFO Vishwas Setia sold a total of 2,922 shares of Voting Common Stock on April 15 and April 16, 2026.
- The sales were conducted to satisfy mandatory tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, the CFO retains beneficial ownership of 392,627 shares of the company.
- The shares were sold at weighted average prices ranging from $26.87 to $27.49 per share.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was strictly for tax compliance purposes and does not reflect a change in the executive's outlook on the company.
Positives
- The transaction was purely administrative, intended to cover tax liabilities rather than a discretionary divestment of equity.
- The reporting person maintains a significant remaining stake of 392,627 shares, indicating continued alignment with shareholder interests.
Negatives
- The sale represents a reduction in the direct equity holdings of a key executive.
Risks
- None identified; this is a routine regulatory filing regarding tax withholding.
Future Outlook
No forward-looking guidance or strategic outlook was provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that mandatory sell-to-cover transactions are standard corporate practice for executives receiving equity-based compensation and do not typically signal a change in management sentiment regarding company performance.
Comparison to Industry Standards
- The transaction follows standard SEC compliance procedures for executive tax obligations common among publicly traded biotechnology firms.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was a routine tax-related sell-to-cover event.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 04/15/2026 | Date of initial share sale for tax withholding. |
| 04/16/2026 | Date of subsequent share sales for tax withholding. |
| 04/17/2026 | Date of filing for the Form 4 statement. |
Keywords
MapLight Therapeutics, MPLT, Insider Trading, Form 4, CFO, Tax Withholding, Equity Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.